Unexpected tumor reduction in metastatic colorectal cancer patients during SARS-Cov-2 infection.
Ther Adv Med Oncol
; 13: 17588359211011455, 2021.
Article
in English
| MEDLINE | ID: covidwho-1226850
ABSTRACT
Herein, we describe three patients affected by metastatic colorectal cancer (mCRC) experiencing infection by severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) and reduction of disease burden during coronavirus disease 2019 (COVID-19) course. Insights into tumor-associated angiotensin-converting enzyme (ACE)-2 expression and lymphocyte function suggest a correlation between host/SARS-Cov-2 infection and tumor burden reduction. This may shed new light into (a) the infection mechanism of SARS-CoV-2 virus and (b) the multiple aspects of a composite antiviral immune response with potential paradoxical and unexpected applications.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Case report
/
Prognostic study
Language:
English
Journal:
Ther Adv Med Oncol
Year:
2021
Document Type:
Article
Affiliation country:
17588359211011455
Similar
MEDLINE
...
LILACS
LIS